Other limitations include unknown group differences in the risk factors for cognitive decline and AD, including apolipoprotein E ε4 genotypes [47] and inflammation [48], although there were no significant differences between the groups in hypertension, diabetes mellitus, medications, physical performance or depressive moods. This evidence concerns the gene APOE and Alzheimer disease.